These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 11423353)

  • 1. Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy.
    Arlt VM; Pfohl-Leszkowicz A; Cosyns J; Schmeiser HH
    Mutat Res; 2001 Jul; 494(1-2):143-50. PubMed ID: 11423353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New molecular and field evidences for the implication of mycotoxins but not aristolochic acid in human nephropathy and urinary tract tumor.
    Pfohl-Leszkowicz A; Tozlovanu M; Manderville R; Peraica M; Castegnaro M; Stefanovic V
    Mol Nutr Food Res; 2007 Sep; 51(9):1131-46. PubMed ID: 17729220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date.
    Cosyns JP
    Drug Saf; 2003; 26(1):33-48. PubMed ID: 12495362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy.
    Bieler CA; Stiborova M; Wiessler M; Cosyns JP; van Ypersele de Strihou C; Schmeiser HH
    Carcinogenesis; 1997 May; 18(5):1063-7. PubMed ID: 9163697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi).
    Nortier JL; Martinez MC; Schmeiser HH; Arlt VM; Bieler CA; Petein M; Depierreux MF; De Pauw L; Abramowicz D; Vereerstraeten P; Vanherweghem JL
    N Engl J Med; 2000 Jun; 342(23):1686-92. PubMed ID: 10841870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy.
    Schmeiser HH; Bieler CA; Wiessler M; van Ypersele de Strihou C; Cosyns JP
    Cancer Res; 1996 May; 56(9):2025-8. PubMed ID: 8616845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aristolactam I a metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephropathy.
    Stiborová M; Frei E; Breuer A; Bieler CA; Schmeiser HH
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):421-7. PubMed ID: 10445409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH : cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathy.
    Stiborová M; Hájek M; Frei E; Schmeiser HH
    Gen Physiol Biophys; 2001 Dec; 20(4):375-92. PubMed ID: 11989648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of ochratoxin A on DNA adduct formation by the carcinogen aristolochic acid in rats.
    Stiborová M; Bárta F; Levová K; Hodek P; Frei E; Arlt VM; Schmeiser HH
    Arch Toxicol; 2015 Nov; 89(11):2141-58. PubMed ID: 25209566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy.
    Schmeiser HH; Nortier JL; Singh R; Gamboa da Costa G; Sennesael J; Cassuto-Viguier E; Ambrosetti D; Rorive S; Pozdzik A; Phillips DH; Stiborova M; Arlt VM
    Int J Cancer; 2014 Jul; 135(2):502-7. PubMed ID: 24921086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aristolochic acid nephropathy in a Chinese patient: time to abandon the term "Chinese herbs nephropathy"?
    Gillerot G; Jadoul M; Arlt VM; van Ypersele De Strihou C; Schmeiser HH; But PP; Bieler CA; Cosyns JP
    Am J Kidney Dis; 2001 Nov; 38(5):E26. PubMed ID: 11684578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. «Suspects» in etiology of endemic nephropathy: aristolochic acid versus mycotoxins.
    Pepeljnjak S; Klarić MŠ
    Toxins (Basel); 2010 Jun; 2(6):1414-27. PubMed ID: 22069645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dexfenfluramine on aristolochic acid nephrotoxicity in a rat model for Chinese-herb nephropathy.
    Debelle F; Nortier J; Arlt VM; De Prez E; Vienne A; Salmon I; Phillips DH; Deschodt-Lanckman M; Vanherweghem JL
    Arch Toxicol; 2003 Apr; 77(4):218-26. PubMed ID: 12698237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aristolochic acid nephropathy: a worldwide problem.
    Debelle FD; Vanherweghem JL; Nortier JL
    Kidney Int; 2008 Jul; 74(2):158-69. PubMed ID: 18418355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aristolochic acid nephropathy ("Chinese herb nephropathy")].
    Nortier J; Pozdzik A; Roumeguere T; Vanherweghem JL
    Nephrol Ther; 2015 Dec; 11(7):574-88. PubMed ID: 26515658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chinese herbs nephropathy and Balkan endemic nephropathy: toward a single entity, aristolochic acid nephropathy.
    De Broe ME
    Kidney Int; 2012 Mar; 81(6):513-5. PubMed ID: 22373701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for covalent DNA adduction by ochratoxin A following chronic exposure to rat and subacute exposure to pig.
    Faucet V; Pfohl-Leszkowicz A; Dai J; Castegnaro M; Manderville RA
    Chem Res Toxicol; 2004 Sep; 17(9):1289-96. PubMed ID: 15377164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ochratoxin A and aristolochic acid involvement in nephropathies and associated urothelial tract tumours.
    Pfohl-Leszkowicz A
    Arh Hig Rada Toksikol; 2009 Dec; 60(4):465-83. PubMed ID: 20061248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal interstitial fibrosis and urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi).
    Nortier JL; Vanherweghem JL
    Toxicology; 2002 Dec; 181-182():577-80. PubMed ID: 12505369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy.
    Stiborová M; Frei E; Sopko B; Wiessler M; Schmeiser HH
    Carcinogenesis; 2002 Apr; 23(4):617-25. PubMed ID: 11960915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.